Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Textiles Press Releases.
Press releases published on May 12, 2025
Gain Therapeutics Presents Preclinical Data at IAPRD 2025 30th World Congress on Parkinson’s Disease and Related Disorders
GlobeNewswire
·
May 12, 2025
BETHESDA, Md., May 12, 2025 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the next generation of allosteric small molecule therapies, …
ProMIS Neurosciences Announces First Quarter 2025 Financial Results
GlobeNewswire
·
May 12, 2025
First Cohort Completed in PRECISE-AD Trial Evaluating PMN310 in Alzheimer’s Disease Six Month Interim Results Expected in 1H 2026 Topline Results Anticipated by end of 2026 CAMBRIDGE, Massachusetts, May 12, 2025 (GLOBE NEWSWIRE) -- ProMIS Neurosciences …
Farmasiet, Norway’s largest online pharmacy, signs Agillic for advanced customer engagement
GlobeNewswire
·
May 12, 2025
Press release – Copenhagen, 12 May 2025 – Agillic A/S The Norwegian online pharmacy, Farmasiet, signs Agillic for advanced customer engagement to explore untapped business potential. Farmasiet is Norway's largest online pharmacy, delivering thousands of …
Longeveron® Named XPRIZE Healthspan Semifinalist and Top 40 Milestone 1 Award Recipient
GlobeNewswire
·
May 12, 2025
Longeveron selected as a Top 40 Semifinalist based on the feasibility of its stem cell therapy Stem cell therapy laromestorcel being evaluated as potential treatment for Alzheimer’s disease and HLHS, a rare pediatric disease and orphan-designated …
Lulutox Tea Reviews: Is This Detox Tea Worth Buying or Just a Scam?
GlobeNewswire
·
May 12, 2025
HYDE PARK, N.Y., May 12, 2025 (GLOBE NEWSWIRE) -- Lulutox Detox Tea Reviews If you have been feeling bloated, tired, or like your weight just isn’t budging no matter what you try, you’re definitely not alone. A lot of people are in the same boat—eating …
Eviden Awarded Contract for “Kaufhaus des Bundes - Next Generation” Project by the Procurement Office of the Federal Ministry of the Interior (BeschA)
GlobeNewswire
·
May 12, 2025
Press Release Eviden Awarded Contract for “Kaufhaus des Bundes - Next Generation” Project by the Procurement Office of the Federal Ministry of the Interior (BeschA) Together with veenion, Eviden is redesigning the 'KdB NG' procurement platform for more …
Eviden remporte le contrat du service des achats du ministère fédéral de l'Intérieur pour le projet « Kaufhaus des Bundes - Next Generation »
GlobeNewswire
·
May 12, 2025
Communiqué de presse Eviden remporte le contrat du service des achats du ministère fédéral de l'Intérieur pour le projet « Kaufhaus des Bundes - Next Generation » En collaboration avec veenion, Eviden repense la plateforme achat et approvisionnement « KdB …
Curium receives marketing authorization in Switzerland for PYLCLARI® – an innovative 18F-PSMA PET tracer indicated in patients with prostate cancer
GlobeNewswire
·
May 12, 2025
Swissmedic grants marketing authorization for PYLCLARI® in Switzerland b.e. Imaging is marketing authorization holder and has exclusive distribution rights for PYLCLARI® across Switzerland ZURICH, May 12, 2025 (GLOBE NEWSWIRE) -- Curium announced today …
Gilat Expands and Adds to its ESA Antenna Portfolio with a Successful Test Flight of ESR-2030Ku on Eutelsat OneWeb Low Earth Orbit (LEO) Network
GlobeNewswire
·
May 12, 2025
PETAH TIKVA, Israel, May 12, 2025 (GLOBE NEWSWIRE) -- Gilat Satellite Networks Ltd. (NASDAQ: GILT, TASE: GILT), a worldwide leader in satellite networking technology, solutions and services, announced today the successful completion of a series of test …
Invivyd Announces New Pipeline Discovery Program Focused on Monoclonal Antibody Treatment for Measles
GlobeNewswire
·
May 12, 2025
Multiple HCPs have requested from Invivyd a monoclonal antibody (mAb) for treatment of active measles infection and post-exposure prophylaxis to reduce the consequence of outbreaks. Such a medicine could accelerate the pathway to functional eradication of …
Sportradar Reports First Quarter Results
GlobeNewswire
·
May 12, 2025
First Quarter 2025 Highlights Revenue increased 17% to €311 million Profit for the period increased to €24 million and expanded to 7.8% as a percentage of revenue Adjusted EBITDA1 increased 25% to €59 million and Adjusted EBITDA margin1 expanded to 18.9% …
Metsera Reports First Quarter 2025 Financial Results and Continued Portfolio Progress
GlobeNewswire
·
May 12, 2025
MET-097i, a fully biased, monthly, ultra-long acting GLP-1 receptor agonist, is in three ongoing VESPER Phase 2b trials, with data from VESPER-1 expected in mid-2025 MET-233i, a monthly, ultra-long acting amylin analog, is in Phase 1 trials as a …
Optima Health plc - Full Year Trading Update
GlobeNewswire
·
May 12, 2025
The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 as amended by regulation 11 of the Market Abuse (Amendment) (EU Exit) …
Teva’s 2024 Healthy Future Report Highlights Sustainability Progress, Including Surpassed Targets Linked to Financial Strategy
GlobeNewswire
·
May 12, 2025
The Company achieved a 29% reduction in absolute scope 1 and 2 greenhouse gas emissions from 2019 levels, surpassing its target of 25% by 2025, ahead of schedule Teva launched two new programs to help people around the world access the medicines they need, …
TensorStax Raises $5M to Build Deterministic AI Agents for Data Engineers
GlobeNewswire
·
May 12, 2025
SAN FRANCISCO, May 12, 2025 (GLOBE NEWSWIRE) -- TensorStax, the autonomous AI agentic platform for data engineering, today announced it has raised $5 million in Seed funding led by Glasswing Ventures, with participation from Bee Partners and S3 Ventures. …
InStride Named a 2025 World’s Top EdTech Company by TIME and Statista
GlobeNewswire
·
May 12, 2025
LOS ANGELES, May 12, 2025 (GLOBE NEWSWIRE) -- InStride, a leading provider of strategic education benefits and skills development solutions, has been recognized on the TIME World’s Top EdTech Companies 2025 list, ranking #26 globally and #7 among U.S.- …
Lexeo Therapeutics Reports First Quarter 2025 Financial Results and Operational Highlights
GlobeNewswire
·
May 12, 2025
Announced positive interim data for LX2006 from Phase 1/2 studies in Friederich ataxia (FA) cardiomyopathy; frataxin expression and LVMI improvement exceeded co-primary target thresholds for planned registrational study LX2006 registrational study expected …
Avalo Reports First Quarter 2025 Financial Results and Recent Business Updates
GlobeNewswire
·
May 12, 2025
Mike Heffernan appointed as Chairman of the Board Topline data from Phase 2 LOTUS trial of AVTX-009 for the treatment of hidradenitis suppurativa expected in 2026 Cash on hand of approximately $125 million as of March 31, 2025 expected to provide runway …
Tango Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Highlights
GlobeNewswire
·
May 12, 2025
– Data update from ongoing TNG462 Phase 1/2 monotherapy trial expected 2H 2025 – – Combination trial of TNG462 + Revolution Medicines RAS(ON) inhibitors on track for enrollment 2Q 2025 – – Cash position of $217 million as of March 31, 2025; cash runway …
Harvard Bioscience Announces First Quarter 2025 Financial Results
GlobeNewswire
·
May 12, 2025
HOLLISTON, Mass., May 12, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced financial results for the first quarter ended March 31, 2025. Jim Green, Chairman and CEO, said, “First quarter revenues were in line …